Abstract:Despite experimental studies suggesting a disease-modifying role of oestrogens, results from epidemiological studies on the relation of reproductive characteristics and hormonal exposures with Parkinson disease in women are conflicting. We used the data from the E3N cohort study including 98 068 women aged 40-65 years in 1990 followed until 2018. Parkinson disease was ascertained using a validation process based on drug claim databases and medical records. Reproductive characteristics and hormonal exposures were self-reported (11 questionnaires). Associations of exposures with Parkinson disease incidence were investigated using time-varying Cox proportional hazards regression with a 5-year exposure lag and age as the timescale adjusted for confounders. We identified 1165 incident Parkinson disease cases during a mean follow-up of 22.0 years (incidence rate = 54.7 per 100 000 person-years). Parkinson disease incidence was higher in women with early (<12 years, HR = 1.21, 95% CI = 1.04-1.40) or late age at menarche (≥14 years, HR = 1.18, 95% CI = 1.03-1.35) than in women with menarche at 12-13 years. Nulliparity was not associated with Parkinson disease, but Parkinson disease incidence increased with the number of children in parous women (P-trend = 0.009). Women with artificial (surgical, iatrogenic) menopause were at greater risk than women with natural menopause (HR = 1.28, 95% CI = 1.09-1.47), especially when artificial menopause occurred at an early age (≤45.0 years). Postmenopausal hormone therapy tended to mitigate greater risk associated with artificial or early menopause (≤45.0 years). While fertility treatments were not associated with Parkinson disease overall, ever users of clomiphene were at greater Parkinson disease risk than never users (HR = 1.81, 95% CI = 1.14-2.88). Other exposures (breastfeeding, oral contraceptives) were not associated with Parkinson disease. Our findings suggest that early and late age at menarche, higher parity, and artificial menopause, in particular at an early age, are associated with increased Parkinson disease incidence in women. In addition, there was some evidence that use of exogenous hormones may increase (fertility treatments) or decrease (postmenopausal hormone therapy) Parkinson disease incidence. These findings support the hypothesis that hormonal exposures play a role in the susceptibility to neurodegenerative diseases. If confirmed, they could help to identify subgroups at high risk for Parkinson disease.

Reproductive Factors, Exogenous Estrogen Use, and Risk of Parkinson'S Disease

Differences in Parkinson's Disease Risk with Caffeine Intake and Postmenopausal Hormone Use.

Reproductive characteristics, use of exogenous hormones and Parkinson disease in women from the E3N study

Prenatal and Early Life Factors and Risk of Parkinson'S Disease

Polymorphisms of Caffeine Metabolism and Estrogen Receptor Genes and Risk of Parkinson's Disease in Men and Women.

Hormone Replacement Therapy and Parkinson'S Disease Risk in Women: A Meta-Analysis of 14 Observational Studies

Integration of Risk Factors for Parkinson Disease in 2 Large Longitudinal Cohorts

Dietary Nicotine Intake and Risk of Parkinson Disease: A Prospective Study

Prospective Study of Statin Use and Risk of Parkinson Disease

Alcohol and Risk of Parkinson's Disease in a Large, Prospective Cohort of Men and Women.

Non-Genetic Risk Factors for Parkinson's Disease: An Overview of 46 Systematic Reviews

Prospective Study of Dietary Pattern and Risk of Parkinson Disease

Parkinson's Disease Research in a Prospective Cohort in China

The risk of Parkinson’s disease in women who underwent hysterectomy before the age of menopause

Comparison of risk factors for Parkinson’s disease, coronary events and ischemic stroke

Smoking and Parkinson'S Disease: Using Parental Smoking As A Proxy to Explore Causality

A Prospective Analysis of Airborne Metal Exposures and Risk of Parkinson Disease in the Nurses’ Health Study Cohort

Update: Protective and Risk Factors for Parkinson Disease

Epidemiology and etiology of Parkinson’s disease: a review of the evidence

Use of Ibuprofen and Risk of Parkinson Disease

Erectile Function and Risk of Parkinson'S Disease